Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 464

1.

Cardiac Pacing in Sub-Saharan Africa: JACC International.

Jouven X, Diop BI, Narayanan K, Adoubi A, Ba SA, Balde D, Damorou JM, Diarra MB, Dzudie A, Ferreira B, Houenassi SM, Ikama MS, Kane A, Kane A, Kingue S, Mipinda JB, Mocumbi AO, Niakara A, Ouankou M, Aly Sidi A, Takombe JL, Toure IA, Zabsonré P, Celermajer DS, Lafont A, Dodinot B, Sagnol P, Marijon E; Africa-Pace Investigators from the African Research Network.

J Am Coll Cardiol. 2019 Nov 26;74(21):2652-2660. doi: 10.1016/j.jacc.2019.09.034. Review.

PMID:
31753207
2.

Feasibility of oxygen sensitive cardiac magnetic resonance of the right ventricle in pulmonary artery hypertension.

Sree Raman K, Stokes M, Walls A, Perry R, Steele PM, Burdeniuk C, De Pasquale CG, Celermajer DS, Selvanayagam JB.

Cardiovasc Diagn Ther. 2019 Oct;9(5):502-512. doi: 10.21037/cdt.2019.09.19.

3.

Management of People With a Fontan Circulation: a Cardiac Society of Australia and New Zealand Position statement.

Zentner D, Celermajer DS, Gentles T, d'Udekem Y, Ayer J, Blue GM, Bridgman C, Burchill L, Cheung M, Cordina R, Culnane E, Davis A, du Plessis K, Eagleson K, Finucane K, Frank B, Greenway S, Grigg L, Hardikar W, Hornung T, Hynson J, Iyengar AJ, James P, Justo R, Kalman J, Kasparian N, Le B, Marshall K, Mathew J, McGiffin D, McGuire M, Monagle P, Moore B, Neilsen J, O'Connor B, O'Donnell C, Pflaumer A, Rice K, Sholler G, Skinner JR, Sood S, Ward J, Weintraub R, Wilson T, Wilson W, Winlaw D, Wood A.

Heart Lung Circ. 2019 Nov 14. pii: S1443-9506(19)31458-1. doi: 10.1016/j.hlc.2019.09.010. [Epub ahead of print]

4.

Repair of Less Than Severe Tricuspid Regurgitation during Left Sided Valve Surgery: A Meta-Analysis.

Cao JY, Wales KM, Zhao DF, Seco M, Celermajer DS, Bannon PG.

Ann Thorac Surg. 2019 Oct 4. pii: S0003-4975(19)31493-6. doi: 10.1016/j.athoracsur.2019.08.101. [Epub ahead of print] Review.

PMID:
31589849
5.

Retrospective Validation of the REVEAL 2.0 Risk Score With the Australian and New Zealand Pulmonary Hypertension Registry Cohort.

Anderson JJ, Lau EM, Lavender M, Benza R, Celermajer DS, Collins N, Corrigan C, Dwyer N, Feenstra J, Horrigan M, Keating D, Kermeen F, Kotlyar E, McWilliams T, Rhodes B, Steele P, Thakkar V, Williams T, Whitford H, Whyte K, Weintraub R, Wrobel JP, Keogh A, Strange G.

Chest. 2019 Sep 26. pii: S0012-3692(19)33934-0. doi: 10.1016/j.chest.2019.08.2203. [Epub ahead of print]

PMID:
31563497
6.

Biobanking for discovery of novel cardiovascular biomarkers using imaging-quantified disease burden: protocol for the longitudinal, prospective, BioHEART-CT cohort study.

Kott KA, Vernon ST, Hansen T, Yu C, Bubb KJ, Coffey S, Sullivan D, Yang J, O'Sullivan J, Chow C, Patel S, Chong J, Celermajer DS, Kritharides L, Grieve SM, Figtree GA.

BMJ Open. 2019 Sep 18;9(9):e028649. doi: 10.1136/bmjopen-2018-028649.

7.

The REDUCE FMR Trial: A Randomized Sham-Controlled Study of Percutaneous Mitral Annuloplasty in Functional Mitral Regurgitation.

Witte KK, Lipiecki J, Siminiak T, Meredith IT, Malkin CJ, Goldberg SL, Stark MA, von Bardeleben RS, Cremer PC, Jaber WA, Celermajer DS, Kaye DM, Sievert H.

JACC Heart Fail. 2019 Nov;7(11):945-955. doi: 10.1016/j.jchf.2019.06.011. Epub 2019 Sep 11.

8.

Rugby Player's Aorta: Alarming Prevalence of Ascending Aortic Dilatation and Effacement in Elite Rugby Players.

Kay S, Moore BM, Moore L, Seco M, Barnes C, Marshman D, Grieve SM, Celermajer DS.

Heart Lung Circ. 2019 Jun 28. pii: S1443-9506(19)31323-X. doi: 10.1016/j.hlc.2019.06.714. [Epub ahead of print]

PMID:
31494040
9.

Prevalence and risk factors for low bone density in adults with a Fontan circulation.

D'Ambrosio P, Tran D, Verrall CE, Attard C, Singh MF, Ayer J, d'Udekem Y, Twigg S, Celermajer DS, Cordina R.

Congenit Heart Dis. 2019 Aug 20. doi: 10.1111/chd.12836. [Epub ahead of print]

PMID:
31430042
10.

Natural History of Atherosclerosis and Abdominal Aortic Intima-Media Thickness: Rationale, Evidence, and Best Practice for Detection of Atherosclerosis in the Young.

Skilton MR, Celermajer DS, Cosmi E, Crispi F, Gidding SS, Raitakari OT, Urbina EM.

J Clin Med. 2019 Aug 12;8(8). pii: E1201. doi: 10.3390/jcm8081201. Review.

11.

The common carotid artery provides significant pressure wave dampening in the young adult sheep.

James NL, Milijasevic Z, Ujhazy A, Edwards G, Jermyn K, Mynard JP, Celermajer DS.

Int J Cardiol Heart Vasc. 2019 Mar 22;23:100343. doi: 10.1016/j.ijcha.2019.03.003. eCollection 2019 Jun.

12.

Evaluation and Management of the Child and Adult With Fontan Circulation: A Scientific Statement From the American Heart Association.

Rychik J, Atz AM, Celermajer DS, Deal BJ, Gatzoulis MA, Gewillig MH, Hsia TY, Hsu DT, Kovacs AH, McCrindle BW, Newburger JW, Pike NA, Rodefeld M, Rosenthal DN, Schumacher KR, Marino BS, Stout K, Veldtman G, Younoszai AK, d'Udekem Y; American Heart Association Council on Cardiovascular Disease in the Young and Council on Cardiovascular and Stroke Nursing.

Circulation. 2019 Jul 1:CIR0000000000000696. doi: 10.1161/CIR.0000000000000696. [Epub ahead of print]

PMID:
31256636
13.

Left arm structure and function late after subclavian flap repair of aortic coarctation in childhood.

Dennis MR, Cusick A, Borilovic J, Nicholson C, Derwin T, Puranik R, Celermajer DS.

Cardiol Young. 2019 Jul;29(7):856-861. doi: 10.1017/S1047951119000386. Epub 2019 Jun 20.

PMID:
31218968
14.

Threshold of Pulmonary Hypertension Associated With Increased Mortality.

Strange G, Stewart S, Celermajer DS, Prior D, Scalia GM, Marwick TH, Gabbay E, Ilton M, Joseph M, Codde J, Playford D; NEDA Contributing Sites.

J Am Coll Cardiol. 2019 Jun 4;73(21):2660-2672. doi: 10.1016/j.jacc.2019.03.482.

PMID:
31146810
15.

State-of-the-Art Review: Echocardiography in Pulmonary Hypertension.

Cordina RL, Playford D, Lang I, Celermajer DS.

Heart Lung Circ. 2019 Sep;28(9):1351-1364. doi: 10.1016/j.hlc.2019.03.003. Epub 2019 Apr 30. Review.

PMID:
31109891
16.

Carotid artery wave intensity in mid- to late-life predicts cognitive decline: the Whitehall II study.

Chiesa ST, Masi S, Shipley MJ, Ellins EA, Fraser AG, Hughes AD, Patel RS, Khir AW, Halcox JP, Singh-Manoux A, Kivimaki M, Celermajer DS, Deanfield JE.

Eur Heart J. 2019 Jul 21;40(28):2300-2309. doi: 10.1093/eurheartj/ehz189.

17.

Validation of a cuff-based device for measuring carotid-femoral pulse wave velocity in children and adolescents.

Cai TY, Meroni A, Dissanayake H, Phang M, Avolio A, Celermajer DS, Butlin M, Skilton MR, Qasem A.

J Hum Hypertens. 2019 Mar 15. doi: 10.1038/s41371-019-0191-1. [Epub ahead of print]

PMID:
30877274
18.

Severe right ventricular dilatation after repair of Tetralogy of Fallot is associated with increased left ventricular preload and stroke volume.

Gnanappa GK, Celermajer DS, Zhu D, Puranik R, Ayer J.

Eur Heart J Cardiovasc Imaging. 2019 Sep 1;20(9):1020-1026. doi: 10.1093/ehjci/jez035.

PMID:
30874802
19.

A Tale of Three Gorges in the Yangtze River: Comparing the Prevalence of Metabolic Syndrome According to ATPIII, WHO, and IDF Criteria and the Association with Vascular Health in Modernizing China.

Woo KS, Hu YJ, Chook P, Wei AN, Chan R, Yin YH, Celermajer DS.

Metab Syndr Relat Disord. 2019 Apr;17(3):137-142. doi: 10.1089/met.2018.0091. Epub 2019 Mar 5.

PMID:
30835162
20.

Pacemakers are associated with a higher risk of late death and transplantation in the Fontan population.

Poh CL, Celermajer DS, Grigg LE, Kalman JM, McGuire MA, Gentles TL, Radford DJ, Bullock A, Disney PJS, Winlaw D, du Plessis K, d'Udekem Y.

Int J Cardiol. 2019 May 1;282:33-37. doi: 10.1016/j.ijcard.2019.01.088. Epub 2019 Jan 25.

PMID:
30755335
21.

Weight Gain Trajectories from Birth to Adolescence and Cardiometabolic Status in Adolescence.

Barraclough JY, Garden FL, Toelle BG, Marks GB, Baur LA, Ayer JG, Celermajer DS.

J Pediatr. 2019 May;208:89-95.e4. doi: 10.1016/j.jpeds.2018.12.034. Epub 2019 Feb 6.

PMID:
30738659
22.

Early and late childhood telomere length predict subclinical atherosclerosis at age 14 yrs. - The CardioCAPS study.

Barraclough JY, Skilton MR, Garden FL, Toelle BG, Marks GB, Celermajer DS.

Int J Cardiol. 2019 Mar 1;278:250-253. doi: 10.1016/j.ijcard.2018.12.065. Epub 2018 Dec 22.

PMID:
30595356
23.

Haemodynamic definitions and updated clinical classification of pulmonary hypertension.

Simonneau G, Montani D, Celermajer DS, Denton CP, Gatzoulis MA, Krowka M, Williams PG, Souza R.

Eur Respir J. 2019 Jan 24;53(1). pii: 1801913. doi: 10.1183/13993003.01913-2018. Print 2019 Jan.

24.

Adult Congenital Heart Disease in Australia and New Zealand: A Call for Optimal Care.

Nicolae M, Gentles T, Strange G, Tanous D, Disney P, Bullock A, Grigg L, Chen SSM, Pressley L, Cordina R, Hornung T, O'Donnell C, Celermajer DS.

Heart Lung Circ. 2019 Apr;28(4):521-529. doi: 10.1016/j.hlc.2018.10.015. Epub 2018 Oct 28. Review.

PMID:
30392984
25.

Ablation of Atrial Arrhythmias After the Atriopulmonary Fontan Procedure: Mechanisms of Arrhythmia and Outcomes.

Moore BM, Anderson R, Nisbet AM, Kalla M, du Plessis K, d'Udekem Y, Bullock A, Cordina RL, Grigg L, Celermajer DS, Kalman J, McGuire MA.

JACC Clin Electrophysiol. 2018 Oct;4(10):1338-1346. doi: 10.1016/j.jacep.2018.08.012.

PMID:
30336880
26.

Adverse effects of amiodarone therapy in adults with congenital heart disease.

Moore BM, Cordina RL, McGuire MA, Celermajer DS.

Congenit Heart Dis. 2018 Nov;13(6):944-951. doi: 10.1111/chd.12657. Epub 2018 Sep 21.

PMID:
30239160
27.

Pulmonary vasodilator therapies are of no benefit in pulmonary hypertension due to left heart disease: A meta-analysis.

Cao JY, Wales KM, Cordina R, Lau EMT, Celermajer DS.

Int J Cardiol. 2018 Dec 15;273:213-220. doi: 10.1016/j.ijcard.2018.09.043. Epub 2018 Sep 12.

PMID:
30224253
28.

Body Fatness and Cardiovascular Health in Newborn Infants.

Dissanayake HU, McMullan RL, Kong Y, Caterson ID, Celermajer DS, Phang M, Raynes-Greenow C, Polson JW, Gordon A, Skilton MR.

J Clin Med. 2018 Sep 11;7(9). pii: E270. doi: 10.3390/jcm7090270.

29.

The National Echocardiography Database Australia (NEDA): Rationale and methodology.

Strange G, Celermajer DS, Marwick T, Prior D, Ilton M, Codde J, Scalia GM, Stewart S, Bulsara M, Gabbay E, Playford D.

Am Heart J. 2018 Oct;204:186-189. doi: 10.1016/j.ahj.2018.07.001. Epub 2018 Jul 17.

PMID:
30098706
30.

Strikingly Different Atheroprotective Effects of Apolipoprotein A-I in Early- Versus Late-Stage Atherosclerosis.

Morton J, Bao S, Vanags LZ, Tsatralis T, Ridiandries A, Siu CW, Ng KM, Tan JTM, Celermajer DS, Ng MKC, Bursill CA.

JACC Basic Transl Sci. 2018 May 30;3(2):187-199. doi: 10.1016/j.jacbts.2017.11.004. eCollection 2018 Apr.

31.

Hepatic and renal end-organ damage in the Fontan circulation: A report from the Australian and New Zealand Fontan Registry.

Wilson TG, d'Udekem Y, Winlaw DS, Cordina RL, Celermajer DS, Wheaton GR, Bullock A, Gentles TL, Weintraub RG, Justo RN, Grigg LE, Radford DJ, Hardikar W, Cheung M, Cain TM, Rao P, Alexander SI, Ayer J, Verrall C, Du Plessis K, Chapman J, Rice K, Barry J, Zannino D, Iyengar AJ; Australian and New Zealand Fontan Registry.

Int J Cardiol. 2018 Dec 15;273:100-107. doi: 10.1016/j.ijcard.2018.07.118. Epub 2018 Jul 25.

PMID:
30060970
32.

Efficacy and adverse effects of sotalol in adults with congenital heart disease.

Moore BM, Cordina RL, McGuire MA, Celermajer DS.

Int J Cardiol. 2019 Jan 1;274:74-79. doi: 10.1016/j.ijcard.2018.06.066. Epub 2018 Jun 20.

PMID:
29954667
33.

Reference range for brachial artery flow-mediated dilation in healthy Chinese children and adolescents.

Li AM, Celermajer DS, Chan MH, Sung RY, Woo KS.

Hong Kong Med J. 2018 Jun;24 Suppl 3(3):36-38. No abstract available.

34.

Usefulness of thrombosis and inflammation biomarkers in chronic thromboembolic pulmonary hypertension-sampling plasma and surgical specimens.

Skoro-Sajer N, Gerges C, Gerges M, Panzenböck A, Jakowitsch J, Kurz A, Taghavi S, Sadushi-Kolici R, Campean I, Klepetko W, Celermajer DS, Lang IM.

J Heart Lung Transplant. 2018 Sep;37(9):1067-1074. doi: 10.1016/j.healun.2018.04.003. Epub 2018 Apr 25.

PMID:
29802084
35.

Cohort profile: The Childhood Asthma Prevention Study (CAPS).

Garden FL, Toelle BG, Mihrshahi S, Webb KL, Almqvist C, Tovey ER, Brew BK, Ayer JG, Skilton MR, Jones G, Ferreira MAR, Cowie CT, Weber-Chrysochoou C, Britton WJ, Celermajer DS, Leeder SR, Peat JK, Marks GB.

Int J Epidemiol. 2018 Dec 1;47(6):1736-1736k. doi: 10.1093/ije/dyy078. No abstract available.

PMID:
29800224
36.

Renin-angiotensin-aldosterone inhibition improves right ventricular function: a meta-analysis.

Cao JY, Lee SY, Phan K, Celermajer DS, Lal S.

Heart Asia. 2018 May 3;10(1):e010999. doi: 10.1136/heartasia-2018-010999. eCollection 2018. Review.

37.

Fenofibrate effects on carotid artery intima-media thickness in adults with type 2 diabetes mellitus: A FIELD substudy.

Harmer JA, Keech AC, Veillard AS, Skilton MR, Watts GF, Celermajer DS; FIELD Vascular Study Investigators.

Diabetes Res Clin Pract. 2018 Jul;141:156-167. doi: 10.1016/j.diabres.2018.05.006. Epub 2018 May 26.

PMID:
29763709
38.

Noninvasive assessment of autonomic function in human neonates born at the extremes of fetal growth spectrum.

Dissanayake HU, McMullan RL, Gordon A, Caterson ID, Celermajer DS, Phang M, Raynes-Greenow C, Skilton MR, Polson JW.

Physiol Rep. 2018 Apr;6(8):e13682. doi: 10.14814/phy2.13682.

39.

Causes of death in a contemporary adult congenital heart disease cohort.

Yu C, Moore BM, Kotchetkova I, Cordina RL, Celermajer DS.

Heart. 2018 Oct;104(20):1678-1682. doi: 10.1136/heartjnl-2017-312777. Epub 2018 Apr 17.

PMID:
29666178
40.

Corrigendum to: "The NLRP3 inflammasome and the emerging role of colchicine to inhibit atherosclerosis-associated inflammation" [Atherosclerosis. 2018 Feb;269:262-271].

Martínez GJ, Celermajer DS, Patel S.

Atherosclerosis. 2018 Jun;273:157. doi: 10.1016/j.atherosclerosis.2018.03.043. Epub 2018 Apr 11. No abstract available.

PMID:
29655831
41.

Reply to: "Inhibitory effects of colchicine on inflammasomes".

Martínez GJ, Celermajer DS, Patel S.

Atherosclerosis. 2018 Jun;273:155-156. doi: 10.1016/j.atherosclerosis.2018.03.042. Epub 2018 Mar 28. No abstract available.

PMID:
29628279
42.

In-depth haemodynamic phenotyping of pulmonary hypertension due to left heart disease.

Gerges C, Gerges M, Fesler P, Pistritto AM, Konowitz NP, Jakowitsch J, Celermajer DS, Lang IM.

Eur Respir J. 2018 May 24;51(5). pii: 1800067. doi: 10.1183/13993003.00067-2018. Print 2018 May.

43.

Early Outcomes of Hypoplastic Left Heart Syndrome Infants: Meta-Analysis of Studies Comparing the Hybrid and Norwood Procedures.

Cao JY, Lee SY, Phan K, Ayer J, Celermajer DS, Winlaw DS.

World J Pediatr Congenit Heart Surg. 2018 Mar;9(2):224-233. doi: 10.1177/2150135117752896.

PMID:
29544421
44.

Long-Term Follow-up of Adults Following the Atrial Switch Operation for Transposition of the Great Arteries - A Contemporary Cohort.

Dennis M, Kotchetkova I, Cordina R, Celermajer DS.

Heart Lung Circ. 2018 Aug;27(8):1011-1017. doi: 10.1016/j.hlc.2017.10.008. Epub 2017 Oct 31.

PMID:
29525133
45.

Clinical Outcomes in Adolescents and Adults After the Fontan Procedure.

Dennis M, Zannino D, du Plessis K, Bullock A, Disney PJS, Radford DJ, Hornung T, Grigg L, Cordina R, d'Udekem Y, Celermajer DS.

J Am Coll Cardiol. 2018 Mar 6;71(9):1009-1017. doi: 10.1016/j.jacc.2017.12.054.

46.

Lower limb exercise generates pulsatile flow into the pulmonary vascular bed in the setting of the Fontan circulation.

Cordina R, Celermajer DS, d'Udekem Y.

Cardiol Young. 2018 May;28(5):732-733. doi: 10.1017/S104795111800015X. Epub 2018 Feb 28.

PMID:
29486809
47.

Evaluation of the relationship between ventricular end-diastolic pressure and echocardiographic measures of diastolic function in adults with a Fontan circulation.

Cordina R, Ministeri M, Babu-Narayan SV, Ladouceur M, Celermajer DS, Gatzoulis MA, Uebing A, Li W.

Int J Cardiol. 2018 May 15;259:71-75. doi: 10.1016/j.ijcard.2018.02.045. Epub 2018 Feb 12.

48.

Long-term outcomes of single-ventricle palliation for pulmonary atresia with intact ventricular septum: Fontan survivors remain at risk of late myocardial ischaemia and death.

Elias P, Poh CL, du Plessis K, Zannino D, Rice K, Radford DJ, Bullock A, Wheaton GR, Celermajer DS, d'Udekem Y.

Eur J Cardiothorac Surg. 2018 Jun 1;53(6):1230-1236. doi: 10.1093/ejcts/ezy038.

PMID:
29444216
49.

Subcutaneous treprostinil in congenital heart disease-related pulmonary arterial hypertension.

Skoro-Sajer N, Gerges C, Balint OH, Kohalmi D, Kaldararova M, Simkova I, Jakowitsch J, Gabriel H, Baumgartner H, Gerges M, Sadushi-Kolici R, Celermajer DS, Lang IM.

Heart. 2018 Jul;104(14):1195-1199. doi: 10.1136/heartjnl-2017-312143. Epub 2018 Feb 7.

50.

Long term survival of hypoplastic left heart syndrome infants: Meta-analysis comparing outcomes from the modified Blalock-Taussig shunt and the right ventricle to pulmonary artery shunt.

Cao JY, Phan K, Ayer J, Celermajer DS, Winlaw DS.

Int J Cardiol. 2018 Mar 1;254:107-116. doi: 10.1016/j.ijcard.2017.10.040. Epub 2018 Jan 28.

PMID:
29407078

Supplemental Content

Loading ...
Support Center